Seiko Epson Corporation
Seiko Epson Corporation (SEKEF) Financial Performance & Income Statement Overview
Explore the financials of Seiko Epson Corporation (SEKEF), including yearly and quarterly data on income, cash flow, and balance sheets.
Seiko Epson Corporation (SEKEF) Income Statement & Financial Overview
Review Seiko Epson Corporation SEKEF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $339.13B | $349.62B | $337.58B | $336.61B |
| Cost of Revenue | $214.40B | $227.03B | $211.82B | $216.67B |
| Gross Profit | $124.72B | $122.59B | $125.76B | $119.95B |
| Gross Profit Ratio | $0.37 | $0.35 | $0.37 | $0.36 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $109.10B | $99.67B | $98.22B | $96.45B |
| Operating Expenses | $109.10B | $94.67B | $98.22B | $97.48B |
| Total Costs & Expenses | $323.50B | $321.69B | $310.04B | $314.15B |
| Interest Income | $41.00M | $2.90B | $0.00 | $5.05B |
| Interest Expense | $1.10B | $0.00 | $6.52B | $607.00M |
| Depreciation & Amortization | $19.46B | $17.76B | $17.33B | $17.59B |
| EBITDA | $31.74B | $45.69B | $29.80B | $40.06B |
| EBITDA Ratio | $0.09 | $0.13 | $0.09 | $0.12 |
| Operating Income | $15.63B | $27.93B | $27.54B | $22.47B |
| Operating Income Ratio | $0.05 | $0.08 | $0.08 | $0.07 |
| Other Income/Expenses (Net) | -$4.44B | $6.43B | -$21.59B | $4.42B |
| Income Before Tax | $11.19B | $34.35B | $5.95B | $26.89B |
| Income Before Tax Ratio | $0.03 | $0.10 | $0.02 | $0.08 |
| Income Tax Expense | $3.39B | $10.26B | $1.84B | $7.73B |
| Net Income | $7.80B | $24.10B | $4.12B | $19.16B |
| Net Income Ratio | $0.02 | $0.07 | $0.01 | $0.06 |
| EPS | $24.64 | $74.10 | $12.42 | $57.78 |
| Diluted EPS | $24.64 | $74.10 | $12.42 | $57.77 |
| Weighted Avg Shares Outstanding | $316.53M | $325.22M | $331.66M | $331.63M |
| Weighted Avg Shares Outstanding (Diluted) | $316.53M | $325.22M | $331.66M | $331.66M |
The company's financials show resilient growth, with revenue advancing from $336.61B in Q1 2024 to $339.13B in Q4 2024. Gross profit remained healthy with margins at 37% in Q4 2024 compared to 36% in Q1 2024. Operating income hit $15.63B last quarter, sustaining a consistent 5% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $31.74B. Net income dropped to $7.80B, while earnings per share reached $24.64. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan